Dhaka, Bangladesh (BBN)-The Beximco Pharmaceuticals has recommended 10 per cent cash and 5.0 per cent stock dividend, officials said on Thursday.
The board of directors of Beximco Pharmaceuticals proposed the dividend for the year ended on December 31, 2015.
The final approval will come during the annual general meeting (AGM) scheduled to be held on June 4, 2016 at Beximco Industrial Park in Gazipur.
The company has also reported net profit after tax BDT 1,954.28 million, earnings per share (EPS) of BDT 5.06, net asset value (NAV) per share of BDT 58.20 and net operating cash flow per share (NOCFPS) of BDT 4.75 for the year ended on 31.12.15 as against BDT 1,528.30 million, BDT 3.96, BDT 56.87 and BDT 6.02 respectively for the year ended on 31.12.14.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.
In 2014, the company also disbursed 10 per cent cash and 5.0 per cent stock dividend.
BBN/SK/AD